Tower Research Capital (TRC)’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.38K | Buy |
|
|||||
|
2025
Q1 | $9.01K | Buy |
|
|||||
|
2024
Q4 | $12.8K | Buy |
|
|||||
|
2024
Q3 | $8.25K | Sell |
|
|||||
|
2024
Q2 | $81.9K | Buy |
|
|||||
|
2024
Q1 | $3.67K | Sell |
|
|||||
|
2023
Q4 | $56.9K | Sell |
|
|||||
|
2023
Q3 | $61.4K | Buy |
|
|||||
|
2023
Q2 | $24.4K | Sell |
|
|||||
|
2023
Q1 | $96K | Sell |
|
|||||
|
2022
Q4 | $215K | Buy |
|
|||||
|
2022
Q3 | $246K | Buy |
|
|||||
|
2022
Q2 | $39K | Buy |
|
|||||
|
2022
Q1 | $34K | Sell |
|
|||||
|
2021
Q4 | $124K | Buy |
|
|||||
|
2021
Q3 | $82K | Buy |
|
|||||
|
2021
Q2 | $79K | Sell |
|
|||||
|
2021
Q1 | $137K | Buy |
|
|||||
|
2020
Q4 | $18K | Sell |
|
|||||
|
2020
Q3 | $126K | Sell |
|
|||||
|
2020
Q2 | $223K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $4K | Sell |
|
|||||
|
2019
Q3 | $12K | Buy |
|
|||||
|
2019
Q2 | $14K | Buy |
|
|||||
|
2019
Q1 | $8K | Sell |
|
|||||
|
2018
Q4 | $45K | Buy |
|
|||||
|
2018
Q3 | $38K | Buy |
|
|||||
|
2018
Q2 | $39K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $5K | Buy |
|